Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Health Discovery Corporation (HDVY)
Atlanta, GA, US
Health Discovery Corporation (HDC) is a U.S.-based enterprise specializing in pattern recognition. The company utilizes sophisticated mathematical approaches to scrutinize data, primarily within the realm of molecular diagnostics, with the goal of identifying underlying patterns. Its portfolio of intellectual property encompasses Support Vector Machines (SVMs), a class of mathematical algorithms, alongside biomarkers – which are biological indicators or genetic markers signifying specific disease conditions – and its proprietary Fractal Genomic Modeling technology. HDC was founded in 2001 and maintains its principal operations in Atlanta, Georgia.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% | -75.00% | -99.93% | -99.72% | -99.99% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Medical - Healthcare Information Services: +14.2%-99.9%
-
EPS growth Medical - Healthcare Information Services: +43.1%-142.2% Q3'21: -71.4% (vs Q3'20)
-
FCF margin FCF growth · Medical - Healthcare Information Services: +49.2%-65,500.0%
-
EBIT margin Medical - Healthcare Information Services: +8.8%-74,900.0%
-
ROIC Medical - Healthcare Information Services: +5.2%— Q3'21: +308.8% (vs Q3'20)
-
Share dilution Medical - Healthcare Information Services: -0.1%+15.0% Q3'21: +1.0% (vs Q3'20)
-
Debt / EBITDA Net debt/EBITDA · Medical - Healthcare Information Services: -0.74×-0.28× Q3'21: -0.20× (vs Q3'20)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Owner Earnings
Ownership Overview
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Belton | 17.05M | 7.50% | 1.45M | — | — | 15.60M | IN | States | 2011-02-15 | ↗ |
| 2 | 20-5370668 | 15.60M | 6.80% | — | — | — | 15.60M | PN | Delaware | 2011-02-15 | ↗ |
| 3 | 2. | 10.00 | 5.50% | — | 22.80M | — | — | BD, OO | Delaware | 2022-02-14 | ↗ |
Institutional Activity (13F)
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | PROVIDENCE WEALTH ADVISORS, LLC | — -100.0K (-100.0%) | — -10.0 (-100.0%) | 0.00% -0.025 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Hong Zhang | Chief Science Officer | 25.5K | — |
| Mark A. Moore | Vice President of Product Development | 8.8K | — |
| Alan K. Hauser | Chief Executive Officer | — | — |
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for HDVY
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
